# Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.

> **NCT07754409** · — · RECRUITING · sponsor: **Göteborg University** · enrollment: 75 (estimated)

## Conditions studied

- Non-Small Cell Carcinoma of Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07754409
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07754409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07754409, "Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07754409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*